SuperworthBioRestorative Therapies shares outstanding BRTX
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Mar 31, 2026
- 886.4K
- On a year earlier
- +112.1%
- more shares
BioRestorative Therapies had 886.4K diluted shares outstanding on average in Q1 FY26, the quarter to Mar 31, 2026.
That is 112.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 486.9K | +20% |
| FY2024 | 406.1K | +73% |
| FY2023 | 234.1K | +28% |
| FY2022 | 183.1K | +54% |
| FY2021 | 118.6K | +339% |
| FY2020 | 27K | +5873% |
| FY2019 | 452 | +258% |
| FY2018 | 126 | +77% |
| FY2017 | 71 | +25% |
| FY2016 | 57 | +50% |
| FY2015 | 38 | +92% |
| FY2014 | 20 | +84% |
| FY2013 | 11 | +15% |
| FY2012 | 9 | +3% |
| FY2011 | 9 | +56% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY26 | 886.4K | +112% | |
| Q4 FY25 | 486.9K | +20% | |
| Q3 FY25 | 455.8K | +12% | |
| Q2 FY25 | 437K | +8% | |
| Q1 FY25 | 417.9K | +25% | |
| Q4 FY24 | 406.1K | +73% | |
| Q3 FY24 | 406.1K | −34% | |
| Q2 FY24 | 406.1K | +109% | |
| Q1 FY24 | 333.6K | +79% | |
| Q4 FY23 | 234.1K | +28% | |
| Q3 FY23 | 616.2K | +238% | |
| Q2 FY23 | 194.3K | +7% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on BioRestorative Therapies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.